Jorge G. Gomez-Gutierrez

Dr. Jorge G. Gomez-Gutierrez

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Virology
Verified
Journal Article
Closed access
HRHumberto Rodríguez-Rocha
Humberto Rodríguez-Rocha
JGJorge G. Gomez-Gutierrez
Jorge G. Gomez-Gutierrez
AGAracely Garcia-Garcia
Aracely Garcia-Garcia
XRXiao-Mei Rao
Xiao-Mei Rao
LCLan Chen
Lan Chen
HZHeshan Sam Zhou
Heshan Sam Zhou

5 December 2006 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Closed access
PDF file
JGJorge G. Gomez-Gutierrez
Jorge G. Gomez-Gutierrez
KEKutlu G. Elpek
Kutlu G. Elpek
RLRoberto Montes de Oca Luna
Roberto Montes de Oca Luna
HSHaval Shirwan
Haval Shirwan
HZH. Sam Zhou
H. Sam Zhou
KMKelly McMasters
Kelly McMasters

24 September 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
NCNaima Cortes-Perez
Naima Cortes-Perez
ALAlejandra de Moreno de LeBlanc
Alejandra de Moreno de LeBlanc
JGJorge G. Gomez-Gutierrez
Jorge G. Gomez-Gutierrez
JBJean Guy Le Blanc
Jean Guy Le Blanc
Luis Bermudez HumaránLuis Bermudez Humarán
Luis Bermudez Humarán
The characteristics of innate immunity have recently been investigated in depth in several research articles, and original findings suggest that innate immunity also has a memory capacity, which has been named “trained immunity”. This notion has revolutionized our knowledge of the innate immune response. Thus, stimulation of trained immunity represents a therapeutic alternative that is worth exploring. In this context, probiotics, live microorganisms which when administered in adequate amounts confer a health benefit on the host, represent attractive candidates for the stimulation of trained immunity; however, although numerous studies have documented the beneficial proprieties of these microorganisms, their mechanisms of action are not yet fully understood. In this review, we propose to explore the putative connection between probiotics and stimulation of trained immunity.

1 July 2006 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
JGJorge G. Gomez-Gutierrez
Jorge G. Gomez-Gutierrez
VSVinicius Souza
Vinicius Souza
HHHong Ying Hao
Hong Ying Hao
RORoberto Montes de Oca-Luna
Roberto Montes de Oca-Luna
YDYan Bin Dong
Yan Bin Dong
KMKelly McMasters
Kelly McMasters
The PTEN/Akt signal pathway plays an important role in tumorigenesis. Mutations or deletions of PTEN have been observed in up to 60% of melanoma cell lines, resulting in PI3K/Akt activation. The Fo...

1 January 2016 in Virology
Verified
Journal Article
Closed access
JGJorge G. Gomez-Gutierrez
Jorge G. Gomez-Gutierrez
JNJonathan Nitz
Jonathan Nitz
RSRajesh Sharma
Rajesh Sharma
SWStephen L. Wechman
Stephen L. Wechman
EREric Riedinger
Eric Riedinger
KMKelly M. McMasters
Kelly M. McMasters

1 April 2008 in Journal of Virology
Verified
Journal Article
Open access
PDF file
XZXinyu Zheng
Xinyu Zheng
XRXiao-Mei Rao
Xiao-Mei Rao
JGJorge G. Gomez-Gutierrez
Jorge G. Gomez-Gutierrez
HHHongying Hao
Hongying Hao
KMKelly M. McMasters
Kelly M. McMasters
HZHeshan Sam Zhou
Heshan Sam Zhou
Adenoviruses (Ads) with E1B55K mutations can selectively replicate in and destroy cancer cells. However, the mechanism of Ad-selective replication in tumor cells is not well characterized. We have shown previously that expression of several cell cycle-regulating genes is markedly affected by the Ad E1b gene in WI-38 human lung fibroblast cells (X. Rao, et al., Virology 350:418-428, 2006). In the current study, we show that the Ad E1B55K region is required to enhance cyclin E expression and that the failure to induce cyclin E overexpression due to E1B55K mutations prevents viral DNA from undergoing efficient replication in WI-38 cells, especially when the cells are arrested in the G 0 phase of the cell cycle by serum starvation. In contrast, cyclin E induction is less dependent on the function encoded in the E1B55K region in A549 and other cancer cells that are permissive for replication of E1B55K-mutated viruses, whether the cells are in the S phase or G 0 phase. The small interfering RNA that specifically inhibits cyclin E expression partially decreased viral replication. Our study provides evidence suggesting that E1B55K may be involved in cell cycle regulation that is important for efficient viral DNA replication and that cyclin E overexpression in cancer cells may be associated with the oncolytic replication of E1B55K-mutated viruses.